News & Updates
Filter by Specialty:
Regdanvimab for COVID-19 effective against Delta variant
The neutralizing antibody regdanvimab appears to be useful in the treatment of mild-to-moderate COVID-19, with a recent study showing that the drug may prevent disease worsening in patients, including those infected with the Delta variant.
Regdanvimab for COVID-19 effective against Delta variant
13 Jan 2023
KRAS G12C inhibitors show promise in metastatic colorectal and pancreatic cancers
The KRASG12C inhibitors, adagrasib and sotorasib, have shown promising antitumour activity in patients with heavily pretreated metastatic colorectal cancer (mCRC) and metastatic pancreatic cancer, respectively.
KRAS G12C inhibitors show promise in metastatic colorectal and pancreatic cancers
13 Jan 2023
IOP-induced ONH strains negatively tied to retinal sensitivity in glaucoma patients
Optic nerve head (ONH) strains under intraocular pressure (IOP) show a negative association with retinal sensitivity in patients with open-angle glaucoma, according to a study. In particular, high-tension glaucoma (HTG) patients with higher ONH strains are more likely to show lower retinal sensitivities.
IOP-induced ONH strains negatively tied to retinal sensitivity in glaucoma patients
12 Jan 2023
Modified Atkins diet helps control drug-resistant epilepsy
Teen and adult patients with drug-resistant epilepsy may benefit from modified Atkins diet, which has been shown in a recent study to produce improvements in seizure frequency, quality of life (QOL), and behavioural problems as compared with standard drug therapy.
